China Steps Up Funding for AI Driven Drugmakers in Push for Biotech Self Reliance

China is accelerating financial support for artificial intelligence driven drug developers as part of a broader national strategy to strengthen technological self reliance in critical sectors. State backed investment funds are channeling capital into biotech firms that combine advanced computing with pharmaceutical research,